Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EWING 2008 registry and treatment protocol for Ewing sarcoma
NL-OMON46854Active, not recruiting
- Sponsor
- SKion
- Start
- Oct 2011
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of vincristine, ifosfamide, doxorubicin, etoposide, actinomycin D and 6 more in Ewing sarcoma, sponsored by SKion. Started Oct 2011; status: active, not recruiting.
02
Drugs
vincristineifosfamidedoxorubicinetoposideactinomycin D
03
Conditions
Ewing sarcoma
Beyond the preview
Go deeper on NL-OMON46854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46854.